Crescent Biopharma (CBIO) Property, Plant & Equipment (Net) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -0.31% |
| 10 | Crescent Biopharma | 569.36 Mn | 380.20 Mn | - | 66.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.64% |
| Dec 31, 2025 | 51.69% |
| Sep 30, 2025 | 39.49% |
| Jun 30, 2025 | -16.62% |
| Sep 30, 2023 | -41.42% |
| Jun 30, 2023 | -38.11% |
| Mar 31, 2023 | -35.92% |
| Dec 31, 2022 | -33.46% |
| Sep 30, 2022 | -31.04% |
| Jun 30, 2022 | -28.99% |
| Mar 31, 2022 | -28.61% |
| Dec 31, 2021 | -27.23% |
| Sep 30, 2021 | -23.83% |
| Jun 30, 2021 | -21.38% |
| Mar 31, 2021 | -19.34% |
| Dec 31, 2020 | -17.54% |
| Sep 30, 2020 | -16.15% |
| Jun 30, 2020 | -15.16% |
| Mar 31, 2020 | -10.79% |
| Dec 31, 2019 | -7.99% |
| Sep 30, 2019 | 9.09% |
| Jun 30, 2019 | 23.98% |
| Mar 31, 2019 | 25.11% |
| Dec 31, 2018 | 22.45% |
| Sep 30, 2018 | 19.52% |
| Jun 30, 2018 | 20.38% |
| Mar 31, 2018 | 35.89% |
| Dec 31, 2017 | 34.76% |
| Sep 30, 2017 | 32.55% |
| Jun 30, 2017 | 40.22% |
| Mar 31, 2017 | 41.52% |
| Dec 31, 2016 | 38.25% |